AEIMX
Price
$8.66
Change
+$0.06 (+0.70%)
Updated
Apr 22, 6:59 PM EST
DODGX
Price
$251.20
Change
+$2.40 (+0.96%)
Updated
Apr 22, 6:59 PM EST
Ad is loading...

Compare trend and price AEIMX vs DODGX

Header iconAEIMX vs DODGX Comparison
Open Charts AEIMX vs DODGXBanner chart's image
American Century Equity Income G
Price$8.66
Change+$0.06 (+0.70%)
VolumeN/A
CapitalizationN/A
Dodge & Cox Stock I
Price$251.20
Change+$2.40 (+0.96%)
VolumeN/A
CapitalizationN/A
View a ticker or compare two or three
AEIMX vs DODGX Comparison Chart

Loading...

VS
AEIMX vs. DODGX commentary
Apr 23, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AEIMX is a Hold and DODGX is a Hold.

FUNDAMENTALS
Fundamentals
DODGX has more cash in the bank: 110B vs. AEIMX (7.84B). AEIMX pays higher dividends than DODGX: AEIMX (3.17) vs DODGX (1.36). AEIMX was incepted earlier than DODGX: AEIMX (5 years) vs DODGX (59 years). AEIMX is a more actively managed with annual turnover of: 29.00 vs. DODGX (12.00). AEIMX has a lower initial minimum investment than DODGX: AEIMX (0) vs DODGX (2500). DODGX annual gain was more profitable for investors over the last year : 16.61 vs. AEIMX (-0.07).
AEIMXDODGXAEIMX / DODGX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence5 years59 years-
Gain YTD3.1673.50490%
Front LoadN/AN/A-
Min. Initial Investment02500-
Min. Initial Investment IRAN/AN/A-
Net Assets7.84B110B7%
Annual Yield % from dividends3.171.36232%
Returns for 1 year-0.0716.61-0%
Returns for 3 years-2.6614.13-19%
Returns for 5 yearsN/A40.15-
Returns for 10 yearsN/A58.64-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
RCI39.090.55
+1.43%
Rogers Communications
WD92.321.08
+1.18%
Walker & Dunlop
ULH33.50N/A
N/A
Universal Logistics Holdings
WKEY1.97-0.07
-3.43%
WISeKey International Holding Ltd
FHTX5.05-0.25
-4.72%
Foghorn Therapeutics